Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 172
Infectious Diseases Drugs 134
Genomics 106
Liver and Kidney Disorders Drugs 72
Drug Discovery 64
Immune Disorders Drugs 61
Pharmaceuticals 51
Cardiovascular Drugs 50
Biopharmaceuticals 46
Biotechnology 41
Leukemia Drugs 38
HIV/AIDS Drugs 36
Clinical Trials 33
Lymphoma Drugs 30
Respiratory Drugs 29
Musculoskeletal Disorders Drugs 29
Allergy and Immunology 28
Enzymes 26
Pulmonary Medicine 24
Oncology 22
Central Nervous System Drugs 19
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 18
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 13
Hematological Drugs 12
Diagnostics 11
Endocrine and Metabolic Disorders Drugs 11
Hematology 10
Sexual and Reproductive Health Drugs 10
Therapeutic Area 9
Healthcare Services 9
Antibiotics 9
Pharmaceutical Intermediates 8
Optical Disorders Drugs 8
Stem Cells 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Company Reports 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Prostate Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
In Vitro Diagnostics 2
Blood Banking 2
Medical Devices 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

1,070 Results (Page 13 of 54)
- Relevance
  Sort by

Cancer Biologics Market - Global Forecast 2025-2030

 Report
August 2025
187 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

Licensing Deals in Biotechnology 2020-2025

 Report
September 2025
1000 Pages
Global

From

€4362EUR$4,995USD£3,790GBP

Collaboration Deals in Biotechnology 2020-2025

 Report
September 2025
900 Pages
Global

From

€4362EUR$4,995USD£3,790GBP

Antibody Production Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

Regenerative Medicine Market - Global Forecast 2025-2030

 Report
August 2025
198 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Biopharmaceuticals Market - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

OTC Drug and Dietary Supplement Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3921EUR$4,490USD£3,406GBP

Cell Therapy Market 2025-2029

 Report
July 2025
218 Pages
Global

From

€2183EUR$2,500USD£1,897GBP

Biologics Market - Global Forecast 2025-2030

 Report
August 2025
180 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

Living Biological Drugs Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

Pharmaceutical API Manufacturing Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3921EUR$4,490USD£3,406GBP

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
307 Pages
Global

From

€2183EUR$2,500USD£1,897GBP

Cutaneous Lupus Erythematosus Market - Global Forecast 2025-2030

 Report
August 2025
182 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

Respiratory Syncytial Virus Therapeutic Drugs Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

Human Respiratory Syncytial Virus Treatment Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3096EUR$3,545USD£2,690GBP

€3440EUR$3,939USD£2,988GBP

Cancer biologics Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3921EUR$4,490USD£3,406GBP

Biologics Market - Forecasts from 2024 to 2029

 Report
April 2024
121 Pages
Global

From

€2760EUR$3,160USD£2,397GBP

€3450EUR$3,950USD£2,997GBP

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

 Report
July 2023
3600 Pages
United States

From

€7860EUR$9,000USD£6,828GBP

Hepatitis C Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
February 2022
87 Pages
Global

From

€3200EUR$3,925USD£2,877GBP

Biologics Market Report 2025

 Report
March 2025
400 Pages
Global

From

€3921EUR$4,490USD£3,406GBP

1,070 Results (Page 13 of 54)
- 1
- 11
- 12
- 13
- 14
- 15

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.